Pharmacovigilance of Vaccines in the USA (US FDA)
- Aug 30
- 4 min
Pharmacovigilance of Biologics in the USA (US FDA)
- Aug 23
- 3 min
Patent Expiry Alert: Blockbuster Drugs Expected to Lose Protection in the Next Five Years
- Aug 21
- 4 min
Biosimilars: Affordable and Effective Alternatives to Biologics
- Jul 2
- 4 min
Biologics in Autoimmune Diseases: A New Hope for Patients
- Jun 27
- 7 min
Precision Medicine – Key Players and Pipeline
- Jun 26
- 4 min
Precision Medicine – US FDA Regulations and Reimbursement Policies
- Jun 7
- 3 min
Biopharmaceutical Alliance Launched by India, South Korea, US, Japan, and EU
- Nov 28, 2023
- 4 min
Registration of Biologics in Malaysia (NPRA)
- Sep 6, 2023
- 5 min
Biologics and Biosimilar Regulations and Registration in South Korea
- Sep 1, 2023
- 7 min
Biologics and Biosimilars Regulation and Registration in India (CDSCO)
- Aug 31, 2023
- 5 min
Biologics and Biosimilar Regulation and Registration in Japan (PMDA)
- Aug 28, 2023
- 5 min
Biologics and Biosimilar Regulations and Registration in the European Union (EU) (EMA)
- Aug 23, 2023
- 5 min
Biologics and Biosimilars Regulations and Registration in Mexico (COFEPRIS)
- Aug 18, 2023
- 5 min
Biologics and Biosimilars Regulations and Registration in China (NMPA)
- Aug 17, 2023
- 5 min
Biologics and Biosimilar Regulations and Registration in Brazil
- Aug 9, 2023
- 5 min
Biologics and Biosimilars Regulations, Registration Process in the USA (FDA)
- Jul 27, 2023
- 7 min
Pharmaceutical Regulations and Registration in Australia
- Jun 20, 2023
- 2 min
Expanded Access by USA FDA for Investigational Drugs
- Jun 20, 2023
- 2 min
Named Patient Program in India (CDSCO)
Insights
Global, Concurrent, Experience Based
Deep dive and engage in insightful discourse driven by concurrent global regulatory scenarios, industry trends and Artixio’s real-time experience across the product value chain. Whitepapers, research articles, landscape reports and case studies to help you stay ahead of the curve.